• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10 Orthopedic Device Firms
    • Buyers' Guide
    • Events
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10 Orthopedic Device Firms
  • Buyers' Guide
  • Events
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    Top Features
    From Nitinol to Nanotubes: A Materials Science Roundtable

    In Good Repair: Trauma Technologies Under Review

    Anxious Undertones: A Review of 2019

    Automated Analysis Advantages for Part Validation

    Tried and True Metalworking
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy

    Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand

    TriMed Closes Out FDA Warning Letter

    FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System

    OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy

    TriMed Closes Out FDA Warning Letter

    Sounding Board: Looking Back at 2019 and Gazing at 2020

    OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application

    Clinical Study of Cell Therapy for Disc Degeneration Clears Final Planned Safety Review
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Sounding Board: Looking Back at 2019 and Gazing at 2020

    Molybdenum-Rhenium Biomaterial: Something ‘MoRe’?

    New Exoskeleton Shoulders Rehab Burden for Stroke Patients

    Repairing Knee Cartilage Defects with the Patient's Own Cells

    Compamed 2019 Preview Report
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    ARCH Medical Solutions

    Edge International/Supra Alloys

    Oberg Medical

    Orthopedic Innovation Pty. Ltd.

    Donatelle
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10 Orthopedic Device Firms
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Features

    A Little Extreme: Factors Impacting the Extremities Implants Segment

    3D printing, surgical planning, and innovations that simplify procedures increasingly are shaping the global extremities market.

    A Little Extreme: Factors Impacting the Extremities Implants Segment
    The Arthrosurface OVO & OVOMotion with Inlay Glenoid Implant Systems prevent further damage to the joint while maintaining the patient’s native anatomy, motion and activity level. Image courtesy of Arthrosurface Inc.
    A Little Extreme: Factors Impacting the Extremities Implants Segment
    Placement of the Cartiva Synthetic Cartilage Implant (SCI). Image courtesy of Wright Medical Group N.V.
    A Little Extreme: Factors Impacting the Extremities Implants Segment
    The DynaFORCE Lapidus System LC Plate from CrossRoads Extremity Systems. Image courtesy of PR Newswire.
    Related CONTENT
    • Past Dues: A Review of Industry in 2018
    • FX Shoulder USA Begins Clinical Study on Stemless Reversed Total Shoulder
    • Sounding Board: 2018 Reflections and Looking Ahead
    • Wright Announces Organizational Changes
    • Spinal Elements Announces New Chairman
    Michael Barbella, Managing Editor05.23.19
    The Bird is grounded again. And for quite a while this time, too.

    Few in the New York Yankees organization were surprised by first baseman Greg Bird’s move to the injured list in mid-April. The 26-year-old, after all, has been plagued by injuries since turning professional eight years ago, and has never played a full season with the 27-time World Series champions. MLB data show Bird has played in only 186 regular season games with the team over the past four years and has missed more than 370 due to shoulder, foot, elbow, and ankle ailments.

    “Unfortunately, it is a little bit of his story so far, not being fully healthy,” Yankees Manager Aaron Boone said on April 16 after placing Bird on the injured list with a left plantar fascia tear. “Even the times he’s been able to play through things, they’ve held him back to a point. I still fully believe he [Bird] can be an impact hitter in this league, but you’ve got to stay healthy to be able to do that. And that’s been the biggest challenge. We’ll continue to try to find a way to help him be at his healthiest all the time and hopefully we get to a point where that happens.”

    The Yankees won’t get to that point this season: Bird is out at least through May 27 as he waits for his foot to heal. The good news is Bird won’t need surgery (the tear in the connective tissue spanning the bottom of the foot usually heals well on its own) but the bad news is the average healing time for plantar fascia tears is 12 weeks. That means Bird could potentially miss half the season.

    Once more.

    Perhaps more important than the timetable for Bird’s return, however, is the company he’s keeping while recuperating. Roughly a dozen Yankees currently are sidelined along with Bird, nursing injuries ranging from strained calves and sore backs to inflamed shoulders and surgically repaired elbows. Center fielder Jacoby Ellsbury is Bird’s kindred spirit among the Yankees’ walking wounded, as he also is recovering from plantar fasciitis.

    “It’s crazy,” first baseman Luke Voit (Bird’s replacement) told The New York Times after an April 28 game against the San Francisco Giants. “It’s like we have a new face in our locker room every day.”

    One of those new faces was infield sub D.J. LeMahieu, who left that Giants game with a bruised right knee from a foul ball two days earlier. “It’s been the story of the season...” he mused to the Times.

    It’s also a story that could have lasting impacts. Though many of the injuries vexing the Yankee lineup this season are relatively minor (small-joint strains, sprains, tightness, inflammation), they possibly could lead to more substantial problems in the future. Ankle sprains, for example, can beget re-injury (often in the same spot), joint damage, chronic instability, and ACL (anterior cruciate ligament) troubles. Human and animal studies, in fact, suggest the effects of a sprained ankle can be more substantial and lingering than previously thought, potentially altering the ability and frequency of movement for life.

    One analysis showed lower activity levels among college students with past sprains, while other studies involving mice chronicled a lifetime of fewer movements among the injured rodents.

    Despite the parallels, though, researchers were hesitant to link the studies’ conclusions (mice and mortals are so very different, they noted). Nevertheless, the data proves that ankle sprains should not be taken lightly.

    “The ankle is the base of the body,” study leader Tricia Hubbard-Turner, kinesiology professor at UNC-Charlotte, told the Times. “Don’t ignore a sprain.”

    Consider yourself warned, Clint Frazier.

    Fortunately, the Yankees outfielder is not without options should the Grade 2 ankle sprain he suffered last month haunt him in the future. Stabilization help is available through Arthrex Inc.’s InternalBrace, a seatbelt-like device that allows bruised ligaments to heal physiologically, or the Talus HemiCAP, a joint restoration system designed to precisely match a patient’s cartilage surface. Developed by Franklin, Mass.-based Arthrosurface, the HemiCAP implant consists of a screw that pairs with a contoured cap covering the damaged cartilage (and healthy tissue as well); the system, according to the company, aims to prevent further joint damage while maintaining the patient’s native anatomy and motion.

    Other future ankle options for Frazier include Wright Medical Group N.V.’s GRAFTJACKET regenerative tissue matrix and BIOFIBER CM, a collagen-coated, resorbable, biologically-derived fiber scaffold for tendon repair.

    More alternatives are likely to surface the longer Frazier (a.k.a., “Red Thunder”) and his teammates play professional baseball. A steady increase in sports-related injuries, combined with rising osteoporosis rates and the planet’s aging population, is projected to boost the global foot and ankle segment a market-leading 8.7 percent annually through 2025, industry data indicate. The potential for new discoveries and innovations also is expected to fuel growth.

    “The reason foot and ankle is the fastest-growing [extremity] segment is because there is still so much research to do,” Paragon 28 co-founder, president, and CEO Albert DaCosta noted in a Business in Focus article last spring. “Whereas with the knee, there are fewer procedures to consider, with the foot we have hundreds of techniques for addressing just a bunion deformity. There are several large segments like bunion deformities, fracture fixation, and flat foot reconstruction; within each of these categories there are hundreds of procedures for us to consider and improve.”

    Such considerations and improvements have led to dozens of innovations since the company’s 2010 birth, including treatments for flat feet, bunions, and hammertoe. Paragon 28’s newest addition to the latter product portfolio is the TenoTac soft tissue fixation system, a product that aims to both streamline procedures and give surgeons more flexibility in their technique and approach to hammertoe issues.

    Launched in February, the TenoTac system uses a titanium threaded implant and a simple insertion method to obtain optimal fixation of soft tissue to bone. Temporary fixation occurs once the implant is inserted and fixation takes place when the dorsal and plantar teeth bite into the bone. The implant is made in three sizes to fit different patient anatomies and comes with minimal instruments to provide a less invasive solution for tendon transfers.

    Paragon 28 claims TenoTac embodies a unique surgical approach compared to traditional methods for flexor tendon transfers, as it corrects the deformity without releasing tissue attachments distally by balancing plantar and dorsal tension.

    “We are creating specific products for each indication and each area of the foot, with consideration of blood supply, soft tissue coverage, and weight-bearing requirements for that area,” DaCosta explained to Business in Focus. “That is how we are creating technologies specific to the foot.”

    That’s how other companies are creating solutions, too. Extremity Medical has developed a cannulated PEEK hammertoe device for osteotomy fixation and reconstructing the lesser toes after corrective procedures for hammertoe, claw toe, and mallet toe. Similarly, Memphis, Tenn.-based CrossRoads Extremity Systems has devised a line of implants for treating forefoot, midfoot, and rearfoot conditions (DynaFORCE), along with devices for Plantar Plate repair and hammertoe deformity.

    Additionally, market newcomer Nvision Biomedical Technologies—which formerly focused only on spinal implants—is now testing the foot/ankle sector waters with its PEEK-OPTIMA hammertoe correction system. The San Antonio, Texas-headquartered firm claims its Vector system is the first U.S. Food and Drug Administration (FDA)-approved foot and ankle implant made from PEEK-OPTIMA, and is the first lower extremity device to use Structural Encoding to enable the FDA-required Unique Device Identification.

    Hammertoe and bunion correction solutions are portfolio staples at Additive Orthopaedics LLC, Centric Medical, In2Bones Global Inc., and Novastep Inc. as well, but these firms are also striving for distinction through innovation or anatomical defect. In2Bones opted for the latter choice, developing a soft tissue release system (ClearGuard) that enables surgeons to minimally invasively treat various conditions, including gastrocnemius strains/tears, tarsal tunnel syndrome, Morton’s neuroma, and plantar fasciitis.

    Take heed, Greg Bird and Jacoby Ellsbury.

    Centric Medical, Novastep, and Additive Orthopaedics, meanwhile, are gunning for prominence via technology: Centric manufactures a customized external fixator (SATURN); Novastep sells size-specific, pre-shaped allograft bone wedges (biofit); and Additive Orthopaedics is leveraging one of the industry’s hottest trends to make bone wedges, bone segments, and patient-specific (3D-printed) locking lattice plates that ultimately will become the cornerstone of an integrated surgical planning system the company hopes to launch later this year.

    “There will always be a need for traditional off-the-shelf orthopedic devices, but in cases of implant revisions, limb salvage, and trauma, using printing to manufacture a patient-specific device can potentially lead to a better outcome,” Additive Orthopaedics president Greg Kowalczyk said upon the FDA’s mid-January approval of the company’s lattice plates. “Although we are still in the early stages for 3D printed patient-specific implants, it has been a terrific journey developing the market in foot and ankle orthopaedics.”

    While that market shows promise, it likely will be years (possibly decades) before its value approaches that of the overall foot/ankle sector, estimated to be worth more than $6.46 billion within the next six years. Growth most certainly will come from the proliferation of age- and lifestyle-related conditions (osteoarthritis and diabetes, particularly) as well as product and technological advancements that simplify procedures, reduce hospitalization, and provide quality patient care.

    “Growth is being driven by innovations that make procedures easier, more predictable to perform, and more efficient for the healthcare system,” stated Julie Dewey, senior vice president and chief communications officer at Wright Medical Group. “Lower extremities growth is being driven by end-stage ankle arthritis, specifically total ankle replacement, as well as innovative implants that keep patients moving. There is also growing interest around minimally invasive solutions that get patients back on their feet quicker with less pain and an improved cosmetic result.”

    Wright Medical is aiding patient recovery and movement with its PROstep MIS System and Cartiva Synthetic Cartilage Implant, the latter of which was inherited through the company’s $435 million acquisition of Cartiva Inc. last summer. The artificial cartilage implant is used as an alternative to fusion to reduce pain and maintain motion in the big toe joint. It is the only PMA-approved product for treating great toe osteoarthritis, according to the firm.

    Composed of a biocompatible, durable, low-friction organic polymer, Cartiva reduces joint pain without sacrificing the foot’s natural movement, thereby enabling patients to retain their mobility and range of motion.

    Clinical studies have linked Cartiva to durable pain relief, sustainable functional improvement, and a better range of motion (a 25 percent increase) compared with fusion.

    The PROstep MIS also has been clinically proven to improve outcomes, with studies showing the product to significantly reduce perioperative pain, shorten hospital stays, and minimize the risk of wound complications.

    Developed specifically for foot and ankle surgery, the PROstep system provides a minimally invasive (MI), procedurally integrated solution that features specially designed implants and instruments for percutaneous foot surgery. The PROstep System is used to treat various forefoot and hindfoot conditions, including bunions (one of the most common foot deformities).

    The MI surgery is performed through small 3-5mm incisions rather than the 3- to 5-inch cuts used in standard bunion surgery. Osteotomies also are less invasive with the PROstep System, as doctors use a rotating burr tool instead of a micro saggital saw.

    In addition to solutions like PROstep and Cartiva, Wright Medical is helping improve patient outcomes and control healthcare costs through its preoperative planning technology, an innovation that has become more of a competitive tool in the era of value-based medicine. Most orthopedic implant makers have developed such systems in recent years as they strive to improve procedural accuracy and better treat musculoskeletal conditions.

    Wright Medical’s PROPHECY Preoperative Navigation System for total ankle replacements allows doctors to visualize patients’ anatomies and anticipate potential surgical contingencies before the actual procedure. Using a computed tomography (CT) scan, the system models a patient’s defective joint and simulates the replacement surgery, helping engineers craft a better-fitting implant. A study of ankle replacement surgeries using the PROPHECY Navigation System found the tibial component size to be accurate in 98 percent of cases and alignment to be within 5 degrees or less of the target in 100 percent of subjects.

    Indeed, the PROPHECY system offers multiple benefits to both patients and caregivers: Patients receive a longer-lasting, more anatomically compatible joint (which lowers the risk of revision surgery), while caregivers reduce OR time through a streamlined procedure (which ultimately saves hospitals money). A win-win for all parties, certainly.

    “Surgical planning is here to stay,” Dewey told Orthopedic Design & Technology. “We believe this is the future of orthopedic healthcare, and we believe we are well-positioned to be a market leader with software platforms both now and in the future.”

    Wright Medical is attempting to ensure its future market status with the establishment of a new digital division that will oversee the company’s digital surgery strategy. Announced in early May, the division is tasked with developing new platforms, accelerating surgical solutions, and driving software tech across the business.  

    The division will build upon the company’s existing BLUEPRINT 3D planning software, which allows surgeons to simulate the position of a shoulder prosthesis using CT imaging. The software provides doctors with a three-dimensional view of the shoulder as well as the ability to digitally rotate through the complete range of motion in any direction in order to choose the best possible implant for patients.

    “We have committed ourselves to the development of our BLUEPRINT software platform that will deliver not only surgical planning but the creation of a digital ecosystem that has value elements for all of the stakeholders involved in patient care,” Dewey noted. “We believe that software-enabled solutions like BLUEPRINT are the future.”

    Many of Wright Medical’s rivals share that philosophy as well: Exactech Inc. has devised software that instantly reconstructs the scapula in 3D, and Zimmer Biomet Holdings Inc. sells a preoperative planning platform that creates “pinpoint” accurate patient-specific surgical guides for anatomic and reverse shoulder arthroplasty candidates.

    Both techniques are the focus of a Web platform developed by DePuy Synthes and Materialise NV to improve the digital planning, design, and ordering of patient-specific 3D printed guides for shoulder surgery. The platform debuted last spring at the American Academy of Orthopaedic Surgeons annual meeting.

    “...this collaboration will empower more orthopaedic surgeons to discover the benefits of online planning...” Materialise founder/CEO Wilfried Vancraen declared at the time of the launch. “3D planning is gaining popularity with orthopedic surgeons performing shoulder operations.”


    And that popularity is bound to grow over the next half-decade as more geriatrics seek to avoid infirmity and more athletes look to bypass (or briefly visit) injured lists.

    ResearchAndMarkets.com data estimate the worldwide shoulder replacement market to grow 7.6 percent annually over the next five years to reach $1.9 billion. Potential headwinds during the forecast period include postoperative complications and implant costs.

    “Patient needs will drive the development of new devices. As the market share grows for shoulder arthroplasty, revisions will become more frequent due to volume and the active aging population,” said Baptiste Martin, CEO of FX Shoulder USA Inc., the Dallas, Texas-based subsidiary of French firm FX Solutions S.A.S., that provides and distributes shoulder replacement devices in the United States. “There is a trend to follow revisions, particularly in cases involving bone loss of the glenoid, and to develop specific prostheses to treat patients and (potentially) improve outcomes and post-operative range of motion.”

    FX Shoulder is focusing on the arthroplasty trend with its FDA-cleared Humeris and Humelock product portfolios; the Humelock II and Humelock Reversed are offered with optional screws (depending on surgeons’ preference for cement). FX Solutions also offers a stemless device (Easytech) for patients with arthritis and good bone quality, but it is now only approved in Europe.

    The company, however, is attempting to expand its use across the pond, having launched in December 2018 an FDA-approved Investigational Device Exemption clinical study of the Easytech Reversed stemless shoulder prosthesis. Twelve U.S. surgeons at nine sites are participating in the trial. 

    “The Easytech Reversed may be exactly what the U.S. market is in need of,” Martin said, “and a reversed stemless prosthesis could potentially be the future of shoulder arthroplasty.”

    It certainly seems that way. Market research shows a growing use of stemless implants in shoulder arthroplasty as surgeons seek to simplify revision procedures and prevent stem-related complications. Doctors also are finding an incentive for use through the increasing number of clinical studies proving the efficacy of stemless implants. A September 2017 study demonstrated nine-year clinical outcome comparability of stemless shoulder devices to that of third- and fourth-generation standard shoulder arthroplasty, as well as significant improvements in patient satisfaction.

    Stemless implants are superficially similar to a resurfacing except for their thicker metaphyseal anchorage and larger component head. Contrary to their name, these devices have a short stem, but it does not enter the diaphysis of the bone like a stemmed implant; rather, it remains completely in the humeral neck mataphysis.

    Despite its growing popularity, stemless arthroplasty is more prominent in Europe than the United States. Only a handful of these solutions are currently available in America, including Arthrex’s Eclipse, Wright Medical’s Simpliciti, Zimmer Biomet’s Sidus Stem-Free Shoulder, and Arthrosurface’s OVO Primary Stemless Shoulder System with Inlay Glenoid.

    Arthrosurface’s OVO device was approved by the FDA last spring and first implanted in August. Touted as the only ovoid (egg)-shaped implant on the market, the OVO helps surgeons avoid overstuffing the joint, improves patients’ range of motion, and reduces pain. Moreover, the prosthesis uses a taper post that secures into dense, subchondral bone for strong fixation, and the inlay glenoid implant significantly reduces glenoid loosening due to the elimination of “rocking horse” effect.

    “The shoulder market is exciting in the sheer volume of procedures, and the continued adoption and improvement of high-performance shoulder arthroplasty devices,” Arthrosurface CEO Steve Ek said. “The market now has many examples of devices that are entering the second and third generations of their designs. Therefore, I think we are starting to see more consistent and reproducible results with these devices. At the same time, patients and surgeons are starting to demand a greater level of performance and function from these devices. Where once the goal was just to mitigate pain, now I believe the expectation is the presumed elimination of pain but also the restoration of a high level of function.”

    Care to verify that, Greg Bird? 
    Related Searches
    • novastep
    • tissue
    • technology
    • osteoarthritis
    Suggested For You
    ODT Forum Program Notebook ODT Forum Program Notebook
    Meniscus Repair Systems Market Expected to Grow 8.7 Percent Through 2028 Meniscus Repair Systems Market Expected to Grow 8.7 Percent Through 2028
    Justifying the Hype of Robotic Orthopedic Surgery Justifying the Hype of Robotic Orthopedic Surgery
    FDA OKs Zimmer Biomet FDA OKs Zimmer Biomet's ROSA ONE Spine System for Robotically-Assisted Surgeries
    AAOS News: Arthrosurface Launches Patellofemoral WaveKahuna Arthroplasty System AAOS News: Arthrosurface Launches Patellofemoral WaveKahuna Arthroplasty System
    AAOS News: Zimmer Biomet Exhibiting Ecosystem of Solutions AAOS News: Zimmer Biomet Exhibiting Ecosystem of Solutions
    Paragon 28 Launches First-of-its-Kind Soft Tissue Fixation Device for Foot and Ankle Paragon 28 Launches First-of-its-Kind Soft Tissue Fixation Device for Foot and Ankle
    Zimmer Biomet Appoints Senior Vice President, Chief Human Resources Officer Zimmer Biomet Appoints Senior Vice President, Chief Human Resources Officer
    FDA Clearance for Zimmer Biomet’s ROSA Knee System for Robotically-Assisted Surgeries FDA Clearance for Zimmer Biomet’s ROSA Knee System for Robotically-Assisted Surgeries
    FDA OKs Additive Orthopaedics FDA OKs Additive Orthopaedics' Patient-Specific 3D Printed Locking Lattice Plates
    Spinal Elements Announces New Chairman Spinal Elements Announces New Chairman
    Wright Announces Organizational Changes Wright Announces Organizational Changes
    Sounding Board: 2018 Reflections and Looking Ahead Sounding Board: 2018 Reflections and Looking Ahead
    FX Shoulder USA Begins Clinical Study on Stemless Reversed Total Shoulder FX Shoulder USA Begins Clinical Study on Stemless Reversed Total Shoulder
    Past Dues: A Review of Industry in 2018 Past Dues: A Review of Industry in 2018

    Related Features

    • 3-D Printing/Additive Mfg. | Machining & Tooling | Materials | Molding
      From Nitinol to Nanotubes: A Materials Science Roundtable

      From Nitinol to Nanotubes: A Materials Science Roundtable

      While new materials are being made available, orthopedic device makers still lean on the well-established options for most new development.
      Mark Crawford, Contributing Writer 12.02.19

    • Biologics | Spine/Neurology | Trauma/Sports
      In Good Repair: Trauma Technologies Under Review

      In Good Repair: Trauma Technologies Under Review

      Novel technologies offer new approaches to fixing traumatic injuries when accidents happen.
      Sam Brusco, Associate Editor 12.02.19

    • MIS/Robotics | Packaging & Sterilization
      Anxious Undertones: A Review of 2019

      Anxious Undertones: A Review of 2019

      Despite a healthy U.S. economy and solid corporate growth, the medtech industry was wracked with worries in 2019.
      Michael Barbella, Managing Editor 12.02.19


    • Biocompatibility & Testing
      Automated Analysis Advantages for Part Validation

      Automated Analysis Advantages for Part Validation

      Accomplishing part fabrication validation can be better facilitated through the incorporation of automated protocols.
      Edward Jaeck, Vice President of Strategic Growth and Business Development, Lowell Inc. 09.17.19

    • Machining & Tooling
      Tried and True Metalworking

      Tried and True Metalworking

      While device manufacturers are curious about newer parts fabrication technologies, they still rely heavily on traditional machining providers.
      Mark Crawford, Contributing Writer 09.17.19

    • Biocompatibility & Testing
      Making the Grade: A Testing and Analysis Roundtable

      Making the Grade: A Testing and Analysis Roundtable

      This roundtable discussion examines the technological and regulatory factors affecting the third-party testing and analysis services industry.
      Sam Brusco, Associate Editor 09.17.19


    • Spine/Neurology
      Back in the Game: A Look at Spine Innovations

      Back in the Game: A Look at Spine Innovations

      An examination of truly unique technologies impacting the spinal sector.
      Michael Barbella, Managing Editor 09.17.19

    • Biologics | Bracing/Prosthetics | Extremities | Imaging | Instruments | Large Joint | MIS/Robotics | Spine/Neurology | Trauma/Sports
      The 2019 Top 10 Global Orthopedic Device Firms

      The 2019 Top 10 Global Orthopedic Device Firms

      Robotics and M&A continued to define the orthopedics industry in 2018.
      ODT Staff 08.14.19

    • Coatings/Surface Modification
      Supporting the Surface: A Look at a New Orthopedic Coating Technology

      Supporting the Surface: A Look at a New Orthopedic Coating Technology

      A novel ortho-coating could improve joint replacement outcomes.
      Vicki A. Barbur, Ph.D. and Anthony Duong, Ph.D., Battelle 08.14.19


    • Design | Research & Development
      Designing Complexity Simply

      Designing Complexity Simply

      New technologies and techniques allow orthopedic device developers to more effectively create advanced products.
      Mark Crawford, Contributing Writer 08.14.19

    • Bracing/Prosthetics | Imaging | Large Joint | Trauma/Sports
      Hidden Gems: 6 Orthopedic Technology Innovators of Note

      Hidden Gems: 6 Orthopedic Technology Innovators of Note

      These organizations are offering intriguing technologies to improve orthopedic care and, as such, have piqued the ODT editors’ interests.
      Sam Brusco, Sean Fenske, and Michael Barbella 08.14.19

    • Biologics
      The ABCs of HCT/Ps

      The ABCs of HCT/Ps

      Navigating the complex regulatory pathway of human cell and tissue products.
      Lindsay Kleinwaks, Ph.D., Associate, Regulatory Affairs, MCRA 05.23.19

    • Coatings/Surface Modification | Materials
      Face Value: An Overview of Surface Modification and Coatings

      Face Value: An Overview of Surface Modification and Coatings

      Orthopedic and spinal device surface treatments are necessary for a variety of aesthetic and functional improvements.
      Sam Brusco, Associate Editor 05.23.19

    • 3-D Printing/Additive Mfg. | Coatings/Surface Modification | Contract Manufacturing | Extremities | Finishing | Large Joint | Laser Processing | Machining & Tooling | Materials | Spine/Neurology
      Technology Revision: Changes in Implant Manufacturing

      Technology Revision: Changes in Implant Manufacturing

      Aspects of implant manufacturing are changing, enabling improved fabrication techniques with new material options.
      Mark Crawford, Contributing Writer 05.23.19

    • 3-D Printing/Additive Mfg. | Design | Prototyping
      Additive Manufacturing: A Tool for Driving Innovation

      Additive Manufacturing: A Tool for Driving Innovation

      Production applications for additive manufacturing are growing, but there are considerations to keep in mind.
      Tom Fripp, Founder and Managing Director, Addition Design & Research 03.29.19


    Breaking News
    • FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    • Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand
    • TriMed Closes Out FDA Warning Letter
    • FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System
    • OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • From Nitinol to Nanotubes: A Materials Science Roundtable
    • In Good Repair: Trauma Technologies Under Review
    • Anxious Undertones: A Review of 2019
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Arkema: Bostik Acquires Danish Company LIP
    Axalta Adds New Epoxy Primer to Tufcote Liquid Industrial Coatings Portfolio
    Chromaflo Technologies Promotes Sergio Duenas to Country Manager of Mexico
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs World's First Single-Use Duodenoscope
    Dr. Stephen Hahn Confirmed as New FDA Leader
    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
    Amgen Selects Location For R&D Facility
    Arctoris Opens Oxford R&D Facility
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Prada & L’Oréal Sign Long-Term Licensing Deal
    Happi

    Latest Breaking News From Happi

    Cosmetic Assessments Revealed at CIR Panel
    T-Boz Launches CBD Line
    DRF and Flowerkist Develop CBD Range
    Ink World

    Latest Breaking News From Ink World

    Ripon Printers Adds Ricoh Pro C9210
    LogoJet Opens Bogota, Colombia Office
    Canon Solutions America Powers University of Notre Dame Athletics' Printing Capabilities
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    GSE products provide quality assurance for Pharmalabel
    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    DuPont to Acquire Osmosis Specialist
    Nice-Pak to Expand in Indiana
    Hospeco Launches Compact Fem Hy Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand
    TriMed Closes Out FDA Warning Letter
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    3D Printing Materials Market to Grow at 23.9% CAGR Through 2025: GVR
    Kyocera, TactoTek Collaborate on Injection Molded Structural Electronics Solutions
    Toray Opens R&D Innovation Center for the Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.